Archives

  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br Our mean whole heart doses are consistent with those

    2020-08-28


    Our mean whole MDMB-CHMICA M2 doses are consistent with those of other published estimates for similar regimens (Table E7; available online at https://doi.org/10.1016/j. prro.2019.01.004). Dosimetric uncertainties are larger for cardiac segment doses than for mean whole heart doses because segment doses are more sensitive to interpatient anatomical variability than whole heart doses. Our estimated cardiac doses are subject to several other unavoidable sources of uncertainty that are common to all radiation therapy CT-planning studies, including errors in contouring,18,30 dose calculation algorithms,31 setup,32,33 and errors caused by cardiac and respiratory motion during treatment.34e36
    Conclusions
    Cardiac segment-specific doses may be used to rank segments by higher-versus-lower doses in epidemio-logical studies relating cardiac structure injury to radi-ation dose.17 However, the scope for developing quantitative dose-response relationships for cardiac segment injury based on information from the radiation therapy charts of patients treated before the era of 3-dimensional CT planning is limited because different segment doses are often highly correlated, and segment-specific dose uncertainties are not independent of each other. 
    Acknowledgments
    The authors are grateful to Prof. Mike Partridge, University of Oxford, for his intellectual input.
    Supplementary Data
    References
    1. Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127-2135.
    2. Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378: 1707-1716.
    4. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys. 1999;43:755-762.
    6. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97:419-424.
    8. Hong JC, Rahimy E, Gross CP, et al. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2018;8: e79-e86.
    9. Dess RT, Liss AL, Griffith KA, et al. Ischemic cardiac events following treatment of the internal mammary nodal region using contemporary radiation planning techniques. Int J Radiat Oncol Biol. 2017;99:1146-1153.
    10. Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypo-fractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol. 2008;9:331-341.
    11. Bentzen SM, Agrawal RK, Aird EG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypo-fractionation for treatment of early breast cancer: A randomised trial. Lancet. 2008;371:1098-1107.
    12. Appelt AL, Vogelius IR, Bentzen SM. Modern hypofractionation schedules for tangential whole breast irradiation decrease the frac-tion size-corrected dose to the heart. Clin Oncol (R Coll Radiol). 2013;25:147-152.
    14. Erven K, Jurcut R, Weltens C, et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011;79:1444-1451.
    Practical Radiation Oncology: May-June 2019 Cardiac segment radiation doses breast cancer 171
    15. Lorenzen EL, Taylor CW, Maraldo M, et al. Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: A multi-centre study from Denmark and the UK. Radiother Oncol. 2013;108:254-258. 16. Wennstig AK, Garmo H, Hållström P, et al. Inter-observer variation in delineating the coronary arteries as organs at risk. Radiother Oncol. 2017;122:72-78.
    17. Taylor C, McGale P, Bronnum D, et al. Cardiac structure injury after radiotherapy for breast cancer: Cross-sectional study with individual patient data. J Clin Oncol. 2018;36:2288-2296.
    19. Buenfil AE, Rodríguez-González MF, González GR, Brandan ME. Absorbed dose and transmission factor in blocked fields for radio-therapy treatments with 6 MV X-ray. Clin Transl Oncol. 2006;8: 279-283.